Davis's Drug Guide
ombitasvir/paritaprevir/ritonavir/dasabuvir
To view the entire topic, please log in or purchase a subscription.
Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:
-- The first section of this topic is shown below --
General
Genetic Implications:
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
om-bit-as-vir/par-i-ta-pre-vir/ri-toe-na-vir/da-sa-bue-vir
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Holkira Pak
- Viekira Pak
Ther. Class.
Pharm. Class.
NS5 inhibitors
protease inhibitors
enzyme inhibitors
non-nucleoside NS5B palm
-- To view the remaining sections of this topic, please log in or purchase a subscription --
General
Genetic Implications:
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
om-bit-as-vir/par-i-ta-pre-vir/ri-toe-na-vir/da-sa-bue-vir
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Holkira Pak
- Viekira Pak
Ther. Class.
Pharm. Class.
NS5 inhibitors
protease inhibitors
enzyme inhibitors
non-nucleoside NS5B palm
There's more to see -- the rest of this topic is available only to subscribers.
